AUCTUS BIOLOGICS, INC.
Surface Plasmon Resonance (SPR) optical biosensor chips with proprietary protein-based binding reagents for drug screening and molecular interaction characterization
- Sector
- Biotech
- Headquarters
- LA FAYETTE, NY
- Total capital
- $229K
- Federal grants
- $229K
- 1 award · 2022
- Rank in peer group#12 of 24
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 3
- 2 pending · first 2022
- Rank in peer group#2 of 24
Capital timeline
Latest events
- Federal grantNSF · Phase I · SBIR Phase I:Development of an Optical Biosensor to Facilitate Screening, Validation, and Development of Novel Drugs and their Biological Targets$229K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 24 peers
Line = medianBiotech · Device
- Federal grants#12 · top 50%
- Granted patents#2 · top 8%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 3 granted of 5- GrantedCompositions, Methods, And Systems For Orally Administrable Affinity-based ProteinUSPTOUS 12,030,916
- GrantedCompositions, Methods, And Systems For Affinity-based Protein Identification And PurificationUSPTOUS 11,414,454
- GrantedCompositions, Methods, And Systems For Orally Administrable Affinity-based ProteinUSPTOUS 11,407,791
Show all 5 patent records
- Compositions, Methods, And Systems For Orally Administrable Affinity-based ProteinJul 9, 2024 · US 12,030,916Granted
- Compositions, Methods, And Systems For Affinity-based Protein Identification And PurificationAug 16, 2022 · US 11,414,454Granted
- Compositions, Methods, And Systems For Orally Administrable Affinity-based ProteinAug 9, 2022 · US 11,407,791Granted
- Compositions, Methods, And Systems For Affinity-based Protein Identification And PurificationApplication 18223615Pending
- Compositions, Methods, And Systems For Orally Administrable Affinity-based ProteinApplication PCTUS2019023845Pending
Related companies, and why
- TEMPRIAN ONCOLOGY, INC.Similar federal contract value in Biotech · null in contracts
- Vividion TherapeuticsSimilar federal contract value in Biotech · null in contracts
- AlumisSimilar federal contract value in Biotech · null in contracts
- VIOME LIFE SCIENCES, INC.Similar federal contract value in Biotech · null in contracts
- IMMUDX, LLCSimilar federal contract value in Biotech · null in contracts
- Quince TherapeuticsSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .